igf-1 lr3 cycle length desensitization Late-life targeting of the receptor improves healthspan and lifespan in female mice igf-1 lr3 cycle length desensitization

13 (Suppl 1), S7981 (1992)

doi: 10.1002/glia.22397 52 GrissTVincentEEEgnatchikRChenJMaEHFaubertBet al

Before the promising therapeutic impact of miRNA can be realized, there are several challenges to be addressed, which include but not limited to targeted delivery of oligonucleotides to specific organs, tissues and cell types, poor bioavailability, limited tissue permeability ( via imperfect matching with 3UTRs ( REGULATION OF miRNA EXPRESSION Recently emerged question is how miRNAs are regulated under certain condition such as diseases

Drug-Disease Interactions: No interactions found/established

It operates on the whole body, not just one part

Aerobic glycolysis: meeting the metabolic requirements of cell proliferation